Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

St. Jude Medical (STJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 23,054,430
  • Shares Outstanding, K 285,590
  • Annual Sales, $ 5,541 M
  • Annual Income, $ 880,000 K
  • 36-Month Beta 1.23
  • Price/Sales 3.90
  • Price/Cash Flow N/A
  • Price/Book 5.14
  • Price/Earnings ttm 20.32
  • Earnings Per Share ttm 3.97
  • Most Recent Earnings 0.99 on 10/19/16
  • Next Earnings Date 01/25/17
  • Annual Dividend & Yield 1.24 (1.54%)
  • Most Recent Dividend 0.31 on 09/28/16
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.59 +2.84%
on 12/07/16
81.31 -0.60%
on 01/04/17
+1.80 (+2.28%)
since 12/02/16
3-Month
77.32 +4.53%
on 11/03/16
81.53 -0.87%
on 10/10/16
+0.99 (+1.24%)
since 10/04/16
52-Week
48.83 +65.51%
on 02/11/16
84.00 -3.79%
on 08/08/16
+20.42 (+33.81%)
since 01/04/16

Most Recent Stories

More News
RenalGuard Solutions Appoints Jim Dillon, Former St. Jude Medical and Abiomed Executive, as Chief Executive Officer

MILFORD, MA--(Marketwired - July 10, 2017) - RenalGuard Solutions, Inc. today announced the appointment of Jim Dillon, former St. Jude Medical and Abiomed commercial executive, as Chief Executive Officer....

STJ : 80.82 (+0.16%)
RenalGuard Solutions Appoints Jim Dillon, Former St. Jude Medical and Abiomed Executive, as Chief Executive Officer

MILFORD, MA--(Marketwired - July 10, 2017) - RenalGuard Solutions, Inc. today announced the appointment of Jim Dillon, former St. Jude Medical and Abiomed commercial executive, as Chief Executive Officer....

STJ : 80.82 (+0.16%)
Kurt H. Kruger joins Qualigen's Board of Directors

Qualigen, Inc., a privately owned company that provides rapid, easy to use, fully quantitative diagnostic testing solutions, announced today that its Board of Directors has elected Kurt H. Kruger to the...

BSX : 27.42 (-0.58%)
STJ : 80.82 (+0.16%)
Global Cardiac Ablation Market 2017-2021 - Key vendors are Boston Scientific, Medtronic & St. Jude Medical - Research and Markets

Research and Markets has announced the addition of the "Global Cardiac Ablation Market 2017-2021" report to their offering.

STJ : 80.82 (+0.16%)
St Jude Medical Has Returned 49.2% Since SmarTrend Recommendation (STJ)

SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 16 months, St Jude Medical has returned 49.17% as of today's recent price of $80.82.

STJ : 80.82 (+0.16%)
China Market Report for Multi-Parameter Vital Sign Monitoring 2017

Research and Markets has announced the addition of the "China Market Report for Multi-Parameter Vital Sign Monitoring 2017 - MedCore" report to their offering. For the purposes of this report, medical-surgery...

STJ : 80.82 (+0.16%)
MDT : 85.74 (-0.22%)
India Market Report for Pulse Oximetry 2017

Research and Markets has announced the addition of the "India Market Report for Pulse Oximetry 2017 - MedCore" report to their offering. The market for peripheral pulse oximetry includes stand-alone bedside,...

STJ : 80.82 (+0.16%)
MDT : 85.74 (-0.22%)
China Market Overview for Patient Monitoring Equipment 2017

Research and Markets has announced the addition of the "China Market Overview for Patient Monitoring Equipment 2017 - MedView" report to their offering. The Chinese market for patient monitoring devices...

EW : 115.61 (-0.22%)
HON : 138.49 (+0.90%)
BABY : 36.25 (-5.72%)
STJ : 80.82 (+0.16%)
MDT : 85.74 (-0.22%)
NHNKY : 12.1000 (-2.26%)
Global Next Generation Pacemaker & ICD Market (2017-2023) - Key Players are Medtronic, Biotronik, Boston Scientific, St. Jude Medical, ZOLL Medical Corporation, Medico & Pacetronix - Research and Markets

Research and Markets has announced the addition of the "Global Next Generation Pacemaker & ICD Market Analysis and Forecast (2017-2023) (Focus on Product, End User, and Competitive Landscape)"...

BSX : 27.42 (-0.58%)
STJ : 80.82 (+0.16%)
Global Diagnostic Catheters Market to Grow at a CAGR of 7.3% by 2023 - Increase in Number of Diagnostic & Imaging Centers

Research and Markets has announced the addition of the "Global Diagnostic Catheters Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report to their offering. The global...

EW : 115.61 (-0.22%)
SIEGY : 68.4900 (+0.01%)
ABT : 50.40 (-0.85%)
SYK : 145.75 (-0.21%)
TRMB : 38.36 (-1.11%)
BSX : 27.42 (-0.58%)
TRUMF : 38.1500 (-0.03%)
JNJ : 130.95 (-0.71%)
STJ : 80.82 (+0.16%)
CAH : 77.67 (-0.03%)
MDT : 85.74 (-0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

St. Jude Medical, Inc. is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology...

See More

Support & Resistance

2nd Resistance Point 81.54
1st Resistance Point 81.18
Last Price 80.82
1st Support Level 80.59
2nd Support Level 80.36

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.